Showing 61–72 of 114 results

Sematide 1mg inj

3,000.00
Semaglutide injection 1 mg is an injectable prescription medicine used: along with diet and exercise to improve blood sugar (glucose)

Siformin 50/500 mg

498.00
This medication can be used with or without sulphonylureas to treat diabetes with maturity onset. Additionally, it is utilized as

SITA 50MG TAB

269.99
Sitagliptin is a DPP-4 inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing

SITA MET 50/1000MG TAB

590.00
By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a

SITA MET 50/500MG TAB

328.86
By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a

SITA MET TAB 50/850

584.00
By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a

SITA MET XR 50/500MG TAB.

329.07
Sitagliptin, a DPP-4 inhibitor, enhances the activities of GLP-1 and GIP, which leads to improved glycemic control in patients with

SITAGEN 100MG TAB

540.00
Sitagliptin is a medication that acts as a dipeptidyl peptidase-4 (DPP-4) inhibitor. DPP-4 is a type of enzyme found in

SITAGEN 50MG TAB

356.00
Sitagliptin is a DPP-4 inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing

SITAGLU MET 50/500MG TAB(HILTON)

536.62
Sitagliptin, a DPP-4 inhibitor, enhances the activities of GLP-1 and GIP, which leads to improved glycemic control in patients with

SITAGLU MET 50/850MG TAB(HILTON)

255.00
By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a

SITAPHAGE 50/1000MG

445.00
<h6>By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a